Case3_Merck - Case 3 Merck the FDA and the Vioxx Recall...

Info icon This preview shows pages 1–3. Sign up to view the full content.

Case 3: Merck, the FDA, and the Vioxx Recall TEACHING NOTE FOR: MERCK, the FDA, and the VIOXX RECALL This case illustrates the following themes and concepts discussed in the chapters listed: Theme/Concept Chapter The Corporation and its Stakeholders 1 Public Issues and the Corporation 2 Corporate Social Responsibility 3 Ethics 4 Global Corporate Citizenship 7 Government Regulation 8 Political Influence 9 Consumer Rights 15 Case Synopsis : In 2006, the pharmaceutical giant Merck faced major challenges. The company’s best- selling prescription painkiller, Vioxx, which had been taken by more than 80 million people worldwide for five years, had been implicated in deaths from heart attack and stroke. Now, Merck was faced with a chorus of criticism, a sharp decline in its stock value, and thousands of liability lawsuits. The case describes Merck’s development, testing, and marketing of Vioxx, as well as the company’s relationships with regulators and policymakers. It also describes Merck’s decision in September 2004 to recall the drug voluntarily following new evidence of elevated cardiovascular risk. TEACHING TIP: WHERE TO USE THE CASE IN THE COURSE There are different ways to approach the discussion of this case, depending on where in the course sequence it is used. 1. If used in connection with the topics of corporate social responsibility and ethics and political action by business, it may be used to evaluate Merck’s behavior. In this event, the instructor may wish to focus mainly on questions 1 and 2. 2. If used in connection with the topics of government regulation or consumers as a stakeholder, it may be used to consider the best strategy for government and society to adopt to protect consumers of prescription medicines. In this even, the instructor may wish to focus mainly on questions 3 and 4. 3. If used at the end of the course, it may be used as an integrative case. In this event, the instructor may wish to cover both sets of questions. Case 3-1
Image of page 1

Info icon This preview has intentionally blurred sections. Sign up to view the full version.

Case 3: Merck, the FDA, and the Vioxx Recall TEACHING TIP: VIDEOS Several videos are available that may be used with this case. They should be ordered at least two weeks before they will be shown. “Bad Medicine: Vioxx, FDA, and Drug Approval” NOW Hosted by David Brancaccio January 7, 2005 (approx. 20 minutes) Transcript available online at Streaming video (RealTime player required) available online DVD available for $19.99 from . David Brancaccio hosts a segment on Vioxx and the drug approval process. The clip includes footage of Raymond Gilmartin, CEO of Merck, announcing the recall; television advertisements for Vioxx; an interview with a woman whose 34-year old daughter died of a heart attack while taking Vioxx; and an interview with Dr. David Graham, an FDA scientist who had challenged the safety of Vioxx.
Image of page 2
Image of page 3
This is the end of the preview. Sign up to access the rest of the document.

{[ snackBarMessage ]}

What students are saying

  • Left Quote Icon

    As a current student on this bumpy collegiate pathway, I stumbled upon Course Hero, where I can find study resources for nearly all my courses, get online help from tutors 24/7, and even share my old projects, papers, and lecture notes with other students.

    Student Picture

    Kiran Temple University Fox School of Business ‘17, Course Hero Intern

  • Left Quote Icon

    I cannot even describe how much Course Hero helped me this summer. It’s truly become something I can always rely on and help me. In the end, I was not only able to survive summer classes, but I was able to thrive thanks to Course Hero.

    Student Picture

    Dana University of Pennsylvania ‘17, Course Hero Intern

  • Left Quote Icon

    The ability to access any university’s resources through Course Hero proved invaluable in my case. I was behind on Tulane coursework and actually used UCLA’s materials to help me move forward and get everything together on time.

    Student Picture

    Jill Tulane University ‘16, Course Hero Intern